Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedA new version on 2025-10-28 updates the recruitment status to Active, not recruiting and adds/updates sections including Contacts/Locations, Study Design, Conditions, Oversight, Study Status, Study Identification, and Recruitment Status.SummaryDifference1%

- Check10 days agoChange DetectedA new version entry (Version 21, 2025-01-09) was added to the Record History. It documents an update to the study status and oversight.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

- Check39 days agoChange DetectedUpdated the site/page version from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

- Check53 days agoChange DetectedUpdated to v3.0.2 from v3.0.1; removed the Back to Top element, with no apparent substantive content changes.SummaryDifference0.7%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.